Gland Pharma Ltd.

₹2930

- 18.25 (-0.62%)

04:01 pm - close price

BSE: GLAND

NSE: GLAND

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 62.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 62.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.96Good: 20

🟡

Current Ratio

Bad: 1Current: 4.68Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 10.56Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 1.95Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 62.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 62.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.96Good: 20

🟡

Current Ratio

Bad: 1Current: 4.68Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 10.56Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 1.95Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	1373.42	1545.15	1537.45	1401.71
Expenditure+	1049.35	1188.76	1178.80	1137.31
Other Income+	53.15	37.39	42.15	51.43
Operating Profit	324.08	356.39	358.65	264.40
Interest	6.05	5.28	9.96	5.62
Depreciation and Amortization	81.30	105.34	92.61	91.96
Profit Before Tax	289.89	283.16	298.23	218.24
Tax+	95.81	91.30	105.81	74.48
Net Profit	194.08	191.86	192.42	143.76

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	44007.08	36246.01	56647.22	56165.04	64306.50
Operational Expenses+	28905.56	25998.38	43316.49	43475.80	48011.06
Operating Profit	15101.52	10247.63	13330.73	12689.24	16295.44
Other Income	2239.38	2404.63	1702.35	2136.08	3163.28
OPM %	34.32	28.27	23.53	22.59	25.34
Depreciation and Amortisation	1102.96	1467.36	3445.66	3778.74	4236.67
Interest	52.42	74.47	262.00	420.00	332.79
Profit Before Tax	16185.52	10545.82	11325.42	10626.58	14645.80
Tax	4098.91	2743.58	3636.33	3631.39	4362.19
Net Profit	12116.64	7810.43	7724.60	6985.26	10273.16

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	78336.21	87775.35	106108.09	111728.52	124485.23
Liabilities+	78336.21	87775.35	106108.09	111728.52	124485.23

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	7907.69	3639.68	9967.97	9147.30	10313.87
Cash from Investing Activity	-10026.21	12081.88	-17569.11	17047.36	1377.28
Cash from Financing Activity	348.98	149.19	-7994.16	-4334.76	-4169.71
Net Cash Flow	-1769.54	15870.75	-15595.30	21859.90	7521.44
Opening Cash & Cash Equivalents	4924.63	3188.20	19088.95	3570.88	25562.09
Closing Cash & Cash Equivalents	3188.20	19088.95	3570.88	25562.09	33591.06

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	51.77	51.83	51.83	51.83	51.83	51.83	51.83	51.83	51.83	57.86
Public+	48.23	48.17	48.17	48.17	48.17	48.17	48.17	48.17	48.17	42.14
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	108266	91500	94578	97151	110671	113788	121075	122358	122665	122375

Corporate Actions

288 events in the last 3 years

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	7907.69	3639.68	9967.97	9147.30	10313.87
Cash from Investing Activity	-10026.21	12081.88	-17569.11	17047.36	1377.28
Cash from Financing Activity	348.98	149.19	-7994.16	-4334.76	-4169.71
Net Cash Flow	-1769.54	15870.75	-15595.30	21859.90	7521.44
Opening Cash & Cash Equivalents	4924.63	3188.20	19088.95	3570.88	25562.09
Closing Cash & Cash Equivalents	3188.20	19088.95	3570.88	25562.09	33591.06

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	44007.08	36246.01	56647.22	56165.04	64306.50
Operational Expenses+	28905.56	25998.38	43316.49	43475.80	48011.06
Operating Profit	15101.52	10247.63	13330.73	12689.24	16295.44
Other Income	2239.38	2404.63	1702.35	2136.08	3163.28
OPM %	34.32	28.27	23.53	22.59	25.34
Depreciation and Amortisation	1102.96	1467.36	3445.66	3778.74	4236.67
Interest	52.42	74.47	262.00	420.00	332.79
Profit Before Tax	16185.52	10545.82	11325.42	10626.58	14645.80
Tax	4098.91	2743.58	3636.33	3631.39	4362.19
Net Profit	12116.64	7810.43	7724.60	6985.26	10273.16

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	78336.21	87775.35	106108.09	111728.52	124485.23
Liabilities+	78336.21	87775.35	106108.09	111728.52	124485.23

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	51.77	51.83	51.83	51.83	51.83	51.83	51.83	51.83	51.83	57.86
Public+	48.23	48.17	48.17	48.17	48.17	48.17	48.17	48.17	48.17	42.14
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	108266	91500	94578	97151	110671	113788	121075	122358	122665	122375

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	1373.42	1545.15	1537.45	1401.71
Expenditure+	1049.35	1188.76	1178.80	1137.31
Other Income+	53.15	37.39	42.15	51.43
Operating Profit	324.08	356.39	358.65	264.40
Interest	6.05	5.28	9.96	5.62
Depreciation and Amortization	81.30	105.34	92.61	91.96
Profit Before Tax	289.89	283.16	298.23	218.24
Tax+	95.81	91.30	105.81	74.48
Net Profit	194.08	191.86	192.42	143.76

Ratios

Reported EPS

Bad: 2Current: 62.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 62.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.96Good: 20

🟡

Current Ratio

Bad: 1Current: 4.68Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 10.56Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 1.95Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 62.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 62.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.96Good: 20

🟡

Current Ratio

Bad: 1Current: 4.68Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 10.56Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 1.95Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Gland Pharma Ltd.

₹2930

- 18.25 (-0.62%)

04:01 pm - close price

BSE: GLAND

NSE: GLAND

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

288 events in the last 3 years